Opportunities and Challenges of Using Big Data to Detect Drug-Drug Interaction Risk

dc.contributor.authorQuinney, Sara K.
dc.contributor.departmentObstetrics and Gynecology, School of Medicineen_US
dc.date.accessioned2019-08-30T17:03:23Z
dc.date.available2019-08-30T17:03:23Z
dc.date.issued2019-07
dc.identifier.citationQuinney S. K. (2019). Opportunities and Challenges of Using Big Data to Detect Drug-Drug Interaction Risk. Clinical pharmacology and therapeutics, 106(1), 72–74. doi:10.1002/cpt.1481en_US
dc.identifier.urihttps://hdl.handle.net/1805/20706
dc.language.isoen_USen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1002/cpt.1481en_US
dc.relation.journalClinical Pharmacology and Therapeuticsen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/us*
dc.sourcePMCen_US
dc.subjectHealthcare dataen_US
dc.subjectDrug‐drug interactions (DDIs)en_US
dc.subjectAdverse drug events (ADEs)en_US
dc.subjectBioinformaticsen_US
dc.titleOpportunities and Challenges of Using Big Data to Detect Drug-Drug Interaction Risken_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CPT-106-72.pdf
Size:
105.54 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: